276 Discovery and preclinical characterization of anti-LILRB2 antibodies that rescue T cells from macrophage-mediated immune suppression

• Lauren Loh,
• Peter Probst,
• Huyen Dinh,
• Sam Lam,
• Valerie Wall,
• Francisco Zapata,
• Ramya Chandrasekaran,
• Texia Loh,
• Tom Graddis,
• Myriam Bouchlaka,
• Meghan Zuck,
• Kamal Puri

Affiliations

Lauren Loh

Aptevo Therapeutics, Seattle, WA, USA

Peter Probst

2Kineta, Inc., Seattle, WA, USA

Huyen Dinh

OncResponse Inc., Seattle, WA, USA

Sam Lam

OncResponse Inc., Seattle, WA, USA

Valerie Wall

OncResponse Inc., Seattle, WA, USA

Francisco Zapata

OncResponse Inc., Seattle, WA, USA

Ramya Chandrasekaran

OncResponse Inc., Seattle, WA, USA

Texia Loh

OncResponse Inc., Seattle, WA, USA

Tom Graddis

OncResponse Inc., Seattle, WA, USA

Myriam Bouchlaka

OncResponse Inc., Seattle, WA, USA

Meghan Zuck

OncResponse Inc., Seattle, WA, USA

Kamal Puri

OncResponse Inc., Seattle, WA, USA